Granulocyte-macrophage colony stimulating factor in the aseptic loosening of total hip arthroplasty

被引:0
|
作者
Xu, JW
Konttinen, YT
Waris, V
GomezBarrena, E
Sorsa, T
Santavirta, S
机构
来源
JOURNAL OF ORTHOPAEDIC RHEUMATOLOGY | 1996年 / 9卷 / 03期
关键词
total hip arthroplasty; aseptic loosening; immunohistochemistry; granulocyte macrophage-colony stimulating factor;
D O I
暂无
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Aseptic loosening of total hip arthroplasty (THA) seems to be associated with and perhaps caused by a synovial-like membrane developing at the implant-bone or cement-bone interface. Granulocyte-macrophage colony stimulating factor (GM-CSF) stimulates bone resorption directly and by recruiting and activating osteoclasas. It may link the synovial-like membrane and osteolysis of the surrounding bone. Twenty samples of synovial-like membrane from the implant-bone or cement-bone interface and from the pseudocapsule were obtained from ten patients undergoing hip revision surgery due to aseptic loosening of THA. As a control group, ten samples of non-inflammatory synovial membrane were obtained from knee joints. All samples were stained immunohistochemically, Results were quantitated by a semiautomatic image analysis system. GM-CSF positive cells, mostly macrophages, were found in all periprosthetic tissues. The number of GM-CSF positive cells per mm(2) was higher in synovial-like membrane and pseudocapsule around loose THAs than in the controls (p < 0.01). The results of the present study suggest that GM-CSF is expressed and produced by periprosthetic tissue cells. It may well cause periprosthetic bone loss and aseptic loosening of THA, and deserves more detailed studies as a mediator and potential target in the prevention of loosening.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 50 条
  • [1] GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR
    BURGESS, AW
    LYMPHOKINE RESEARCH, 1984, 3 (02): : 64 - 64
  • [2] REGULATION OF MACROPHAGE ACTIVATION BY GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR
    GRABSTEIN, K
    URDAL, D
    TUSHINSKI, R
    MOCHIZUKI, D
    PRICE, V
    LARSEN, A
    GILLIS, S
    CONLON, P
    JOURNAL OF LEUKOCYTE BIOLOGY, 1986, 40 (03) : 290 - 291
  • [3] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PSORIASIS
    TAKEMATSU, H
    TAGAMI, H
    DERMATOLOGICA, 1990, 181 (01): : 16 - 20
  • [4] MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    BURGESS, AW
    NICE, EC
    METHODS IN ENZYMOLOGY, 1985, 116 : 588 - 600
  • [5] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND VASCULITIS
    DREICER, R
    SCHILLER, JH
    CARBONE, PP
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (01) : 91 - 92
  • [6] Unexpected functions of granulocyte-macrophage colony stimulating factor
    Dranoff, G
    Mulligan, RC
    CANCER GENES: FUNCTIONAL ASPECTS, 1996, 7 : 269 - 280
  • [7] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND PSORIASIS
    KELLY, RI
    MARSDEN, RA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (01) : 144 - 144
  • [8] HEMATOLOGIC EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR
    ULICH, T
    DELCASTILLO, J
    MCNIECE, I
    WATSON, L
    YIN, S
    ANDRESEN, J
    LABORATORY INVESTIGATION, 1990, 62 (01) : A102 - A102
  • [9] Functions of granulocyte-macrophage colony-stimulating factor
    Fleetwood, AJ
    Cook, AD
    Hamilton, JA
    CRITICAL REVIEWS IN IMMUNOLOGY, 2005, 25 (05) : 405 - 428
  • [10] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN NEUTROPENIA
    HOGAN, KR
    PETERS, MD
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (01): : 32 - 35